HPK1 inhibitor reinvigorates exhausted tumor-infiltrating CD8+ T cells and synergizes with anti-PD-1 inhibitor in endometrial cancer and ovarian cancer 3530
Year: 2025
Type: article
Source: The Journal of Immunology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4416446688
FWCI:
Cites:
Cited by:
Related to:
